CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer.
Human papilloma virus (HPV)-induced cervical cancer constitutively expresses viral E6/E7 oncoproteins and is an excellent target for T cell-based immunotherapy. However, not all tumor-infiltrating T cells confer equal benefit to patients, with epithelial T cells being superior to stromal T cells. To...
主要な著者: | Komdeur, F, Prins, T, van de Wall, S, Plat, A, Wisman, G, Hollema, H, Daemen, T, Church, D, de Bruyn, M, Nijman, H |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
Taylor and Francis
2017
|
類似資料
-
Tumor infiltrating CD8/CD103/TIM-3-expressing lymphocytes in epithelial ovarian cancer co-express CXCL13 and associate with improved survival
著者:: Martijn Vlaming, 等
出版事項: (2022-10-01) -
Development of [89Zr]Zr-hCD103.Fab01A and [68Ga]Ga-hCD103.Fab01A for PET imaging to noninvasively assess cancer reactive T cell infiltration: Fab-based CD103 immunoPET
著者:: Xiaoyu Fan, 等
出版事項: (2023-11-01) -
A transcriptionally distinct CXCL13+ CD103+ CD8+ T-cell population is associated with B-cell 2 recruitment and neoantigen load in human cancer
著者:: Workel, H, 等
出版事項: (2019) -
Development of 89Zr-anti-CD103 PET imaging for non-invasive assessment of cancer reactive T cell infiltration
著者:: Danique Giesen, 等
出版事項: (2022-12-01) -
385 Selection of CD8+CD103+CD31- tumor infiltrating lymphocytes (TIL) from bulk cultures enriches tumor-specific reactivity in a patient-agnostic manner
著者:: Steven A Rosenberg, 等
出版事項: (2023-11-01)